These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36804924)

  • 1. A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma.
    Chen H; Li T; Liu Z; Tang S; Tong J; Tao Y; Zhao Z; Li N; Mao C; Shen J; Wan M
    Nat Commun; 2023 Feb; 14(1):941. PubMed ID: 36804924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Universal Chemotactic Targeted Delivery Strategy for Inflammatory Diseases.
    Li T; Liu Z; Hu J; Chen L; Chen T; Tang Q; Yu B; Zhao B; Mao C; Wan M
    Adv Mater; 2022 Nov; 34(47):e2206654. PubMed ID: 36122571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Penetration of Nanolevel Drugs and Micrometer-Level T Cells Promoted by Nanomotors for Cancer Immunochemotherapy.
    Chen H; Shi T; Wang Y; Liu Z; Liu F; Zhang H; Wang X; Miao Z; Liu B; Wan M; Mao C; Wei J
    J Am Chem Soc; 2021 Aug; 143(31):12025-12037. PubMed ID: 34320319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipophilic NO-Driven Nanomotors as Drug Balloon Coating for the Treatment of Atherosclerosis.
    Tang X; Chen L; Wu Z; Li Y; Zeng J; Jiang W; Lv W; Wan M; Mao C; Zhou M
    Small; 2023 Mar; 19(13):e2203238. PubMed ID: 35961946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.
    Catania G; Rodella G; Vanvarenberg K; Préat V; Malfanti A
    Biomaterials; 2023 Mar; 294():122006. PubMed ID: 36701998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier-Free Trehalose-Based Nanomotors Targeting Macrophages in Inflammatory Plaque for Treatment of Atherosclerosis.
    Wu Z; Zhou M; Tang X; Zeng J; Li Y; Sun Y; Huang J; Chen L; Wan M; Mao C
    ACS Nano; 2022 Mar; 16(3):3808-3820. PubMed ID: 35199998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Acidic Microenvironment-Responsive Promodulator Iron Oxide Nanoparticles for Photothermal-Enhanced Chemodynamic Immunotherapy of Cancer.
    Chen S; Lv Y; Wang Y; Kong D; Xia J; Li J; Zhou Q
    ACS Biomater Sci Eng; 2023 Feb; 9(2):773-783. PubMed ID: 36598463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma.
    Hsieh HT; Huang HC; Chung CW; Chiang CC; Hsia T; Wu HF; Huang RL; Chiang CS; Wang J; Lu TT; Chen Y
    J Control Release; 2022 Dec; 352():920-930. PubMed ID: 36334859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.
    Ma B; Sheng J; Wang P; Jiang Z; Borrathybay E
    Int J Nanomedicine; 2019; 14():4541-4558. PubMed ID: 31417257
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1.
    Fahey JM; Stancill JS; Smith BC; Girotti AW
    J Biol Chem; 2018 Apr; 293(14):5345-5359. PubMed ID: 29440272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-driven nanomotors with bowl-shaped mesoporous silica for targeted thrombolysis.
    Tao Y; Li X; Wu Z; Chen C; Tan K; Wan M; Zhou M; Mao C
    J Colloid Interface Sci; 2022 Apr; 611():61-70. PubMed ID: 34929439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of PD-L1 by Nitric Oxide via JNK Activation in A172 Glioblastoma Cells.
    Kiriyama Y; Tani A; Kadoya M; Okamoto R; Nochi H
    Biol Pharm Bull; 2020 Jun; 43(6):1020-1022. PubMed ID: 32201424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin-ferrum nanoparticles enhance photothermal therapy by modulating the tumor immunosuppressive microenvironment.
    Li L; Zhang M; Liu T; Li J; Sun S; Chen J; Liu Z; Zhang Z; Zhang L
    Acta Biomater; 2022 Dec; 154():454-466. PubMed ID: 36243377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upstream signaling events leading to elevated production of pro-survival nitric oxide in photodynamically-challenged glioblastoma cells.
    Fahey JM; Korytowski W; Girotti AW
    Free Radic Biol Med; 2019 Jun; 137():37-45. PubMed ID: 30991141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Ding Y; Sun Z; Gao Y; Zhang S; Yang C; Qian Z; Jin L; Zhang J; Zeng C; Mao Z; Wang W
    Adv Mater; 2021 Aug; 33(34):e2102188. PubMed ID: 34278622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. l-Citrulline restores nitric oxide level and cellular uptake at the brain capillary endothelial cell line (TR-BBB cells) with glutamate cytotoxicity.
    Lee KE; Kang YS
    Microvasc Res; 2018 Nov; 120():29-35. PubMed ID: 29870781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dioscin, a natural steroid saponin, induces apoptosis and DNA damage through reactive oxygen species: a potential new drug for treatment of glioblastoma multiforme.
    Lv L; Zheng L; Dong D; Xu L; Yin L; Xu Y; Qi Y; Han X; Peng J
    Food Chem Toxicol; 2013 Sep; 59():657-69. PubMed ID: 23871826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depolarization of mitochondria in endothelial cells promotes cerebral artery vasodilation by activation of nitric oxide synthase.
    Katakam PV; Wappler EA; Katz PS; Rutkai I; Institoris A; Domoki F; Gáspár T; Grovenburg SM; Snipes JA; Busija DW
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):752-9. PubMed ID: 23329133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of T Cells in Cancer by Nitric Oxide.
    Navasardyan I; Bonavida B
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies.
    Pombo Antunes AR; Scheyltjens I; Duerinck J; Neyns B; Movahedi K; Van Ginderachter JA
    Elife; 2020 Feb; 9():. PubMed ID: 32014107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.